J Hepatol:妊娠期肝内胆汁淤积症使肝胆系统癌症风险增加

2015-04-21 MedSci MedSci原创

妊娠期肝内胆汁淤积症(ICP)是妊娠期最常见的肝胆系统并发症。Wikstrom Shemer EA 等人进行了一项基于人群的队列研究,探究ICP与癌症、免疫介导疾病、心血管疾病的关系。该研究纳入了1973-2009年期间11,388名ICP女性和113,893非ICP女性(对照)。研究结果显示,ICP虽然与妊娠之后的所有癌症发病率无明显相关性(HR 1.07, 95% CI 0.94-1.21),

怎么治疗妊娠期肝内胆汁淤积症

妊娠期肝内胆汁淤积症(ICP)是妊娠期最常见的肝胆系统并发症。Wikstrom Shemer EA 等人进行了一项基于人群的队列研究,探究ICP与癌症、免疫介导疾病、心血管疾病的关系。该研究纳入了1973-2009年期间11,388名ICP女性和113,893非ICP女性(对照)。

研究结果显示,ICP虽然与妊娠之后的所有癌症发病率无明显相关性(HR 1.07, 95% CI 0.94-1.21),但是却与肝脏、胆道癌症密切相关(肝脏癌症HR 3.61, 95% CI 1.68-7.77, 胆道癌症 2.62, 95% CI 1.26-5.46)。同时研究显示,ICP与妊娠后免疫介导疾病密切相关(HR 1.28, 95% CI 1.19-1.38),尤其是糖尿病(HR 1.47, 95% CI 1.26-1.72)。甲状腺疾病(HR 1.30, 95% CI 1.14-1.47)、牛皮癣(HR 1.27, 95% CI 1.07-1.51)、炎症性多发关节病变(HR 1.32, 95% CI 1.11-1.58)、克罗恩病(HR 1.55, 95% CI 1.14-2.10),但是并没有发现ICP与溃疡性结肠病的相关性(HR 1.21, 95% CI 0.93-1.58)。数据分析得出,ICP与妊娠后心血管疾病也有小程度的联系(HR 1.12, 95% CI 1.06-1.19)。

研究结果表明,有ICP病史的女性其以后患肝胆系统癌症、免疫介导疾病、以及心血管疾病风险增加。

原始出处:

Wikstrom Shemer EA, Stephansson O, Thuresson M, Thorsell M, Ludvigsson JF, Marschall HU: Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. Journal of hepatology 2015.

本文系Medsci原创编译整理!转载需要先获得授权,并附原文链接。谢谢!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1688903, encodeId=c83816889038d, content=<a href='/topic/show?id=b223834816e' target=_blank style='color:#2F92EE;'>#胆汁淤积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83481, encryptionId=b223834816e, topicName=胆汁淤积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89928680706, createdName=紫砂壶, createdTime=Wed Dec 02 18:23:00 CST 2015, time=2015-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250956, encodeId=1a951250956b0, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426609, encodeId=9c0e142660922, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579147, encodeId=c7fd15e914791, content=<a href='/topic/show?id=372b834e673' target=_blank style='color:#2F92EE;'>#胆汁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83476, encryptionId=372b834e673, topicName=胆汁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0616505872, createdName=108807375_62823132, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21647, encodeId=cec12164ee8, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21648, encodeId=9fee2164881, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1688903, encodeId=c83816889038d, content=<a href='/topic/show?id=b223834816e' target=_blank style='color:#2F92EE;'>#胆汁淤积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83481, encryptionId=b223834816e, topicName=胆汁淤积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89928680706, createdName=紫砂壶, createdTime=Wed Dec 02 18:23:00 CST 2015, time=2015-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250956, encodeId=1a951250956b0, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426609, encodeId=9c0e142660922, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579147, encodeId=c7fd15e914791, content=<a href='/topic/show?id=372b834e673' target=_blank style='color:#2F92EE;'>#胆汁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83476, encryptionId=372b834e673, topicName=胆汁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0616505872, createdName=108807375_62823132, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21647, encodeId=cec12164ee8, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21648, encodeId=9fee2164881, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1688903, encodeId=c83816889038d, content=<a href='/topic/show?id=b223834816e' target=_blank style='color:#2F92EE;'>#胆汁淤积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83481, encryptionId=b223834816e, topicName=胆汁淤积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89928680706, createdName=紫砂壶, createdTime=Wed Dec 02 18:23:00 CST 2015, time=2015-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250956, encodeId=1a951250956b0, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426609, encodeId=9c0e142660922, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579147, encodeId=c7fd15e914791, content=<a href='/topic/show?id=372b834e673' target=_blank style='color:#2F92EE;'>#胆汁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83476, encryptionId=372b834e673, topicName=胆汁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0616505872, createdName=108807375_62823132, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21647, encodeId=cec12164ee8, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21648, encodeId=9fee2164881, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=)]
    2015-04-23 gwc384
  4. [GetPortalCommentsPageByObjectIdResponse(id=1688903, encodeId=c83816889038d, content=<a href='/topic/show?id=b223834816e' target=_blank style='color:#2F92EE;'>#胆汁淤积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83481, encryptionId=b223834816e, topicName=胆汁淤积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89928680706, createdName=紫砂壶, createdTime=Wed Dec 02 18:23:00 CST 2015, time=2015-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250956, encodeId=1a951250956b0, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426609, encodeId=9c0e142660922, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579147, encodeId=c7fd15e914791, content=<a href='/topic/show?id=372b834e673' target=_blank style='color:#2F92EE;'>#胆汁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83476, encryptionId=372b834e673, topicName=胆汁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0616505872, createdName=108807375_62823132, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21647, encodeId=cec12164ee8, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21648, encodeId=9fee2164881, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1688903, encodeId=c83816889038d, content=<a href='/topic/show?id=b223834816e' target=_blank style='color:#2F92EE;'>#胆汁淤积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83481, encryptionId=b223834816e, topicName=胆汁淤积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89928680706, createdName=紫砂壶, createdTime=Wed Dec 02 18:23:00 CST 2015, time=2015-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250956, encodeId=1a951250956b0, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426609, encodeId=9c0e142660922, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579147, encodeId=c7fd15e914791, content=<a href='/topic/show?id=372b834e673' target=_blank style='color:#2F92EE;'>#胆汁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83476, encryptionId=372b834e673, topicName=胆汁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0616505872, createdName=108807375_62823132, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21647, encodeId=cec12164ee8, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21648, encodeId=9fee2164881, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=)]
    2015-04-22 cspcsp

    有用

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1688903, encodeId=c83816889038d, content=<a href='/topic/show?id=b223834816e' target=_blank style='color:#2F92EE;'>#胆汁淤积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83481, encryptionId=b223834816e, topicName=胆汁淤积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89928680706, createdName=紫砂壶, createdTime=Wed Dec 02 18:23:00 CST 2015, time=2015-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250956, encodeId=1a951250956b0, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426609, encodeId=9c0e142660922, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579147, encodeId=c7fd15e914791, content=<a href='/topic/show?id=372b834e673' target=_blank style='color:#2F92EE;'>#胆汁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83476, encryptionId=372b834e673, topicName=胆汁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0616505872, createdName=108807375_62823132, createdTime=Thu Apr 23 13:23:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21647, encodeId=cec12164ee8, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21648, encodeId=9fee2164881, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Wed Apr 22 00:26:00 CST 2015, time=2015-04-22, status=1, ipAttribution=)]
    2015-04-22 cspcsp

    有道理

    0

相关资讯

Gastroenterology:奥贝胆酸有望成为治疗PBC的新药物

原发性胆汁性肝硬化(PBC)是一种自身免疫性肝病,与胆汁淤积有关,依据最新的美国和欧洲的指南,高碱性磷酸酶(ALP)和抗线粒体抗体(AMA)阳性即可诊断PBC,这使PBC的早期诊断率明显提高。 熊去氧胆酸(UCDA)作为唯一批准治疗PBC的药物被广泛应用,然而有多达40%的PBC患者对UDCA治疗反应不良,而且这类患者的肝移植生存率明显低于UDCA治疗反应良好的患者。 奥贝